Latest News Releases From The Newsroom
Major Advancements in Biotech: Enveric Biosciences' Psilocin Prodrug Patent Allowance, Phio Pharma's Breakthrough in Cancer Therapy, and Teva's Strategic Framework
May 18th, 2023
Enveric Biosciences, Inc. (Nasdaq: ENVB) has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a patent application related to their new chemical entity (NCE) psilocin prodrug, known as EB-373. This prodrug. Read more
Monro Falls Short of Q4 Expectations as Micron Technology, Mullen Automotive, and FibroGen Make Positive Pre-Market Moves
May 18th, 2023
Monro, Inc. (Nasdaq: MNRO) has released its financial results for the fourth quarter of fiscal 2023, reporting adjusted earnings per share (EPS) that fell short of market expectations. The company's adjusted EPS for the quarter stood at $0.08, compar. Read more
Initiated with a Buy: Arcellx, Pliant Therapeutics, Tarsus Pharmaceuticals, Varonis Systems
May 18th, 2023
Several companies have recently received initiations with Buy ratings from prominent financial institutions, indicating positive outlooks for their future performance. Arcellx, Inc. (Nasdaq: ACLX) has been initiated with a Buy rating and a price t. Read more
EyePoint Pharma's YUTIQ Sale, Protalix's Milestone Achievement, and Walmart's Q1 Surpass Expectations: Pre-Market Update
May 18th, 2023
EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT) has announced a definitive agreement for the sale of YUTIQ, their fluocinolone acetonide intravitreal implant used in the treatment of chronic non-infectious uveitis affecting the posterior segment of the. Read more
Q1 2023 Earnings Report: KE Holdings and Bath & Body Works Exceed Expectations, Sociedad Química y Minera de Chile Falls Short; Revvity Inks Licensing Deal with AstraZeneca
May 18th, 2023
KE Holdings Inc. (NYSE: BEKE) reported better-than-expected adjusted earnings per share (EPS) for the first quarter of 2023. The company's adjusted EPS stood at $0.43, surpassing the consensus estimate of $0.23. In pre-market trading, $BEKE . Read more
BlackBerry Aims for Financial Growth, Take-Two Interactive Software Shines in Q4 Financial Report
May 17th, 2023
BlackBerry Limited (NYSE: BB) has unveiled its long-term financial targets, outlining its strategic objectives for the future. The company is aiming to achieve substantial improvements in non-GAAP EPS loss and cash flow utilization in FY24, . Read more
FTC to Host Workshop Examining Issues Related to Proposed Changes to the Funeral Rule
May 17th, 2023
Washington D.C. / CRWE PRESS RELEASE / May 17, 2023 - The Federal Trade Commission will hold a public workshop on September 7, 2023 seeking input on proposed changes to the Funeral Rule. The Commission issued an Advance Noti. Read more
National Western Life Group Exploring Strategic Alternatives, Bausch Health Surges on U.S. District Court's Decision, Kura Oncology Initiated with a Buy
May 17th, 2023
National Western Life Group, Inc. (Nasdaq: NWLI) has announced its intention to explore strategic alternatives with the aim of maximizing value for its stockholders. At this stage, no specific decision has been made regarding a sale, merger, or other. Read more
Jack in the Box Beats Estimates, Expands Into New Markets; Remark Holdings Inks Strategic Partnership; AppLovin Upgraded
May 17th, 2023
Jack in the Box Inc. (Nasdaq: JACK) reported operating earnings per share of $1.47 for the second quarter of fiscal year 2023, surpassing the consensus estimate of $1.22 per share. Additionally, the company has made significant expansion announcem. Read more
Immutep's Eftilagimod Alpha Shows Promise in Phase II Trial, Lightning eMotors Reports Q1 Loss and $50M Pre-Paid Advance Deal, BioNTech Upgraded to Buy
May 17th, 2023
Immutep Limited (Nasdaq: IMMP) has received positive feedback from the US Food and Drug Administration (FDA) for its late-stage clinical development plans for Eftilagimod Alpha ("efti") in the treatment of 1st line non-small cell lung cancer. In addi. Read more
Want To Find Some News?
News By Industries
Recent Posts
-
Micron Technology, Jabil, and Birkenstock Earnings Preview: What to Expect
December 15th, 2024Upcoming Earnings: Synopsys, AeroVironment, and nCino in Focus
December 01st, 2024Countdown to Earnings: Salesforce, Marvell Technology, and Okta Take the Stage
December 01st, 2024Fluence Energy, Agilent Technologies, and Woodward Earnings On Deck: A Preview
November 24th, 2024Earnings Preview: Walt Disney, Applied Materials, and Celcuity Take Center Stage
November 11th, 2024
Member Login